What is equipment validation in pharma and why does the ongoing program matter?
Equipment validation in pharma means proving through documented testing that manufacturing or laboratory equipment is installed correctly (IQ), operates within its design parameters (OQ), and performs consistently under real production conditions (PQ). Most organisations invest heavily in the initial three phases but underinvest in the ongoing change control, calibration integration, and periodic review that actually keeps equipment in a validated state over its operational life — which is where inspection findings accumulate.
Most cited gap: The initial IQ/OQ/PQ is complete and documented. The ongoing programme — change control re-qualification assessments, calibration failure impact reviews, and periodic trend analysis — breaks down quietly over time. Regulators expect both.
Equipment vs Software Validation — Why the Same Framework Produces Different Evidence
Both use IQ/OQ/PQ, but the underlying compliance challenge is fundamentally different.
| Dimension | Equipment Validation | Software Validation |
|---|---|---|
| System Nature | Physical systems wear, drift, and degrade over time. | Software does not wear between versions. |
| Risk Focus | Qualification must account for ageing, component replacement, and performance drift across manufacturing campaigns. | Compliance risk comes from configuration drift, vendor updates, and changes in intended use. |
| Re-qualification Triggers | Time, wear, and hardware drift-driven, as well as modification-driven. | Purely change-driven rather than time and wear-driven. |
| Lifecycle Monitoring | Periodic review and physical trend monitoring are mandatory. | Periodic verification focuses on access control, drift, and security configurations. |
The Three Qualification Phases: What Each Actually Proves
Understanding the distinct purpose of each phase prevents the most common documentation gaps.
- IQInstallation Qualification: Is it installed exactly per specification — right services, right instruments, all calibrated at time of IQ?
Key checks include serial numbers, utility connections, safety systems, cleaning procedures, and verified calibration certificates.
Most common gap: Calibration status assumed, not verified at IQ execution - OQOperational Qualification: Does it operate correctly across the full qualified range — targets, boundaries, and challenge conditions?
Key checks include range testing, boundary conditions, challenge tests, and pre-defined acceptance criteria.
Most common gap: Criteria looser than process requirements - PQPerformance Qualification: Does it perform consistently under real production conditions — real product, real operators, real schedules?
Key checks include consecutive production runs, representative process data, and a risk-justified run count.
Most common gap: Run count not risk-justified — defaulting to three
Equipment Qualification Summary Table
Primary question, required evidence, and most common inspection finding for each phase.
| Phase | Primary Question | Key Evidence | Most Common Inspection Gap |
|---|---|---|---|
| IQ | Is it installed correctly with all services and instruments verified? | Installation records, calibration certs, utility checks, serial numbers | Calibration status not verified at IQ execution |
| OQ | Does it operate correctly across the full qualified range? | Range tests, boundary conditions, challenge tests, pre-defined criteria | Acceptance criteria looser than process requirements |
| PQ | Does it perform consistently under real production conditions? | Consecutive production runs, process parameter data, run count justification | Run count not documented and risk-justified — defaulting to three |
Three Areas Most Teams Under-Invest In
The initial qualification passes. These ongoing programme elements break down quietly — and that is where inspection findings come from.
- Change control and re-qualification
Every equipment change — replaced component, modified control parameter, relocated instrument — needs a change control assessment explicitly asking whether re-qualification is required. Many processes skip this question, leaving equipment operating outside its validated state without detection. - Calibration programme integration
Equipment qualification and the calibration programme must be connected. When a critical instrument goes out of calibration, the impact on qualification status must be assessed — not just logged in the calibration system and corrected in isolation. - Periodic review with trend analysis
A periodic review that only checks whether changes have occurred is insufficient. Effective review analyses trend data — process parameter drift, alarm frequency, maintenance history, OOS incidents — and produces a documented conclusion on whether the qualified state is maintained.
How GoVal Manages Equipment Validation Lifecycle
Equipment validation generates significant ongoing documentation — all of it needs to be linked, traceable, and inspection-ready at any moment.
| What You Need | How GoVal Delivers It |
|---|---|
| IQ through PQ in one platform | Full equipment qualification lifecycle with automatic traceability linking URS requirements to executed test results |
| Periodic review alerts | GoVal tracks review due dates for every qualified asset and sends automated alerts before they are overdue |
| Change impact assessment | Every change triggers a structured re-qualification impact assessment with a documented decision before the change is implemented |
| Equipment portfolio dashboard | Qualification status, pending reviews, open deviations, and calibration linkage for every asset in one real-time view |
| Calibration integration | Calibration status linked to qualification records — so a calibration failure automatically flags the affected qualified state for impact review |
| Audit-ready at all times | Complete qualification records available immediately — not compiled over days in response to an inspection notice |
Related Topics
Frequently Asked Questions
What equipment in a pharma facility requires validation? +
Any equipment used in manufacture, processing, packing, testing, or storage where failure could affect product quality or patient safety. This includes manufacturing equipment (tablet presses, filling lines, sterilisers), laboratory equipment (HPLC systems, balances, stability chambers), and utilities directly contacting product (WFI systems, clean steam, compressed gases). Qualification level scales with criticality to product quality.
How long does pharmaceutical equipment validation take? +
Simple laboratory equipment IQ/OQ can be completed in days. Complex manufacturing equipment — filling lines, sterilisers, custom process equipment — typically requires 4–16 weeks for full IQ/OQ/PQ. The biggest time variables are protocol authoring time, calibration readiness at IQ, and the number of consecutive PQ runs required to demonstrate consistent performance.
What is the difference between equipment qualification and process validation? +
Equipment qualification (IQ, OQ, PQ) proves the equipment is installed correctly and performs consistently within specifications. Process validation proves a manufacturing process using that equipment consistently produces product meeting its specifications. Equipment qualification is a prerequisite — you cannot validate a process on unqualified equipment.
When is equipment re-qualification required in pharma? +
After significant changes — component replacement with different specification, relocation, significant repair, control system modification, or changes to operating parameters. Your change control procedure must include a formal re-qualification assessment step. Periodic review trend data may also trigger re-qualification if it shows the equipment drifting from its validated state.
What does EU GMP Annex 15 require for equipment qualification? +
Annex 15 requires a documented qualification lifecycle — URS, IQ, OQ, PQ — with approved protocols before execution, pre-defined acceptance criteria, formal deviation management, and qualification reports. It is more prescriptive than FDA guidance on documentation structure. Satisfying Annex 15 generally satisfies FDA requirements, making it a useful baseline for dual-regulated sites.
How does FDA view equipment qualification versus EU GMP Annex 15? +
Both require equipment qualification with broadly aligned requirements. EU Annex 15 is more prescriptive about documentation structure; FDA emphasises the risk-based approach and connection to process validation. Satisfying Annex 15 generally satisfies FDA requirements as well — making it the stronger baseline for dual-regulated organisations.
What are the most common equipment validation inspection findings? +
The most consistently cited findings: calibration status of critical instruments not verified at IQ execution; OQ acceptance criteria looser than process requirements; PQ run count not documented and risk-justified; change control records not assessing re-qualification need; calibration failures not assessed for impact on qualification status; and periodic reviews that check for changes but do not analyse trend data.
Can GoVal manage equipment qualification alongside computer system validation? +
Yes. GoVal manages both in the same platform — with consistent qualification workflows, shared risk assessment tools, unified audit trail and e-signature infrastructure, automated periodic review alerts, and a portfolio dashboard showing the qualification status of all validated assets simultaneously.
Manage Your Full Equipment Validation Programme in One Place
GoVal gives your team IQ through PQ templates, automated periodic review scheduling, change impact assessments, and a real-time portfolio dashboard — all in one platform built for GMP-regulated environments.